TELA Bio, Inc. Appoints Kurt Azarbarzin as Chairman of Its Board of Directors and to Compensation Committee
April 25, 2019 at 08:30 am EDT
Share
TELA Bio®, Inc. announced the appointment of Kurt Azarbarzin as Chairman of its Board of Directors. Mr. Azarbarzin is also being appointed to the Compensation Committee. Mr. Azarbarzin joined TELA Bio's Board of Directors in 2018. He currently serves as Chairman of the Board of Directors for Standard Bariatrics, Inc., and is also chief technology officer of CONMED Corporation where he leads research and development across all subsidiaries and business units.
TELA Bio, Inc. is a commercial-stage medical technology company. The Company is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patientâs own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall reconstruction. Its OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair. The Company's OviTex products include OviTex 1S, OviTex 2S, and OviTex LPR. Its second portfolio of products, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses unmet needs in plastic and reconstructive surgery. OviTex PRS is indicated for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft-tissue repair.
TELA BIO, INC. 
